PRINGLE LAB - Key Persons
Endocrinologist Aaron Hsueh discovers obestatin, a hormone that supresses appetite and may lead to treatments for obesity.
Job Titles:
- Assistant Professor of Developmental Biology
As a recent graduate from Humboldt State University in Arcata, Ca., Allison received a double B.S. in Marine Biology and Zoology, with an emphasis in Scientific Diving. It was there that she developed an interest in working with marine invertebrates, especially in developmental and larval biology. Currently, Allison is assisting in developing a reliable spawning protocol for Aiptasia, in an attempt to improve spawning efficiency and predictability in the lab. Everyday she has had the pleasure of caring for LOTS of anemones, as well as working with a great group of people. In her spare time, Allison volunteers as an eco-diver for the organization Reef Check, which allows her to take an active role in the conservation of the world's coral and rocky reefs. If Alison isnot working, she is probably hanging out with her husband and two dogs, diving, hiking, or traveling anywhere and everywhere.
Job Titles:
- Associate Professor of Genetics / Research
Pharmacologist Avram Goldstein discovers a chemical in the human brain that could lead to the development of powerful painkillers with fewer undesirable side effects.
Job Titles:
- Research Scientist, Stanford Cancer Institute Core
- Staff Scientist at the Stanford Cancer Institute
Aziz Khan is a staff scientist at the Stanford Cancer Institute, where he develops reproducible pipelines and machine learning methods for integrative analysis of multi-omics data at bulk and single-cell resolution to understand tumor evolution and chromatin regulatory dynamics of tumor growth.
Aziz completed his PhD in Bioinformatics at Tsinghua University, China in 2016 followed by a three year postdoctoral training at the University of Oslo, Norway. During PhD and Postdoc his primary research emphasis was on regulatory genomics and epigenomics. He developed computational methods, tools, and resources to understand the (epi)genomic control of gene regulation in development and disease.
Apart from research, he is advocating for open science, open-source, preprints, and reproducibility in research. He is a contributor for Bioconda and also developed several open-source tools and resources such as JASPAR. He is ASAPbio and eLife Community Ambassador and co-founded ECRcentral (ecrcentral.org), a community initiative for early-career researchers.
Job Titles:
- CARL and ELIZABETH NAUMANN DEAN of the SCHOOL of MEDICINE / VICE PRESIDENT for MEDICAL AFFAIRS, STANFORD UNIVERSITY
Carlo was a mainstay of the lab from 2000 until the end of 2010 and remains connected with us on a part-time basis even as he pursues his current full-time job. His duties as Lab Manager included a bit of everything: handling lab ordering and safety inspections; repairing equipment; overseeing most aspects of the lab move from UNC to Stanford in 2005; performing high-quality experimental work; etc. In his first few years, Carlo helped with a wide variety of yeast studies. But when we decided in 2004 to launch a study of dinoflagellate-cnidarian symbiosis, he became the point person on this project and was primarily responsible for getting it off the ground before we began attracting postdocs and graduate students to the project in 2007. His initials live on in the name for our primary clonal anemone strain (CC7). Carlo's involvement in our collaborative field-work on Ofu Island (American Samoa) led to an offer from the National Park Service to live and work in there full-time, which he began in January 2011. While working full-time at Stanford, Carlo also managed to complete an M.S. in Biology. As a project for one class, he and his friend Josh Meisels (who was then working part-time in the lab) produced a video about the forensic identification of sharks sold on the soup-fin market: Sharks in Hot Water
Job Titles:
- Assistant Professor at California State University, Chico
Job Titles:
- Assistant Professor of Marine Science and Biology at Eckerd College
Job Titles:
- Professor of Biochemistry and, by Courtesy, of Chemical Engineering / Research
Job Titles:
- Advanced Lecturer, Biology
Job Titles:
- PRESIDENT & CEO / STANFORD HEALTH CARE
Job Titles:
- Pathology and Professor of Developmental Biology
Job Titles:
- Dean
- Physician
- Scientist
- Surgeon
- Carl and Elizabeth Naumann Dean of the School of Medicine
- CARL and ELIZABETH NAUMANN DEAN of the SCHOOL of MEDICINE / VICE PRESIDENT for MEDICAL AFFAIRS, STANFORD UNIVERSITY
- Vice Dean Linda M. Boxer
Dean Minor is a leading physician, basic scientist and educator.
Lloyd B. Minor, MD, is a scientist, surgeon, and academic leader. He is the Carl and Elizabeth Naumann Dean of the Stanford University School of Medicine and Vice President for Medical Affairs at Stanford University. Dr. Minor also is a professor of Otolaryngology-Head and Neck Surgery and a professor of Bioengineering and of Neurobiology, by courtesy, at Stanford University.
As dean, Dr. Minor has had an integral role in setting strategy for the clinical enterprise of Stanford Medicine, an academic medical center that includes the Stanford University School of Medicine, Stanford Health Care, and Stanford Medicine Children's Health. With his leadership, Stanford Medicine leads the biomedical revolution in Precision Health. His book, "Discovering Precision Health," describes this shift to more preventive, personalized health care and highlights how biomedical advances are dramatically improving our ability to treat and cure complex diseases. In 2021, Dr. Minor articulated and began realizing a bold vision to transform the future of life sciences at Stanford University and beyond - a multi-decade journey enabled by Precision Health.
In August 2023, Dr. Minor was appointed Vice President for Medical Affairs to lead all matters related to health and medicine at Stanford University.
Before Stanford, Dr. Minor was provost and senior vice president for academic affairs of Johns Hopkins University. Prior to this appointment in 2009, Dr. Minor served as the Andelot Professor and director (chair) of the Department of Otolaryngology-Head and Neck Surgery in the Johns Hopkins University School of Medicine and otolaryngologist-in-chief of The Johns Hopkins Hospital.
With more than 160 published articles and chapters, Dr. Minor is an expert in balance and inner ear disorders perhaps best known for discovering superior canal dehiscence syndrome, a debilitating disorder characterized by sound- or pressure-induced dizziness. He subsequently developed a surgical procedure that corrects the problem and alleviates symptoms.
In 2012, Dr. Minor was elected to the National Academy of Medicine.
Carl and Elizabeth Naumann Dean of the School of Medicine,
Vice President for Medical Affairs, Stanford University,
Professor of Otolaryngology - Head and Neck Surgery, and Professor of Neurobiology and of Bioengineering, by courtesy
Lloyd B. Minor, MD, is a scientist, surgeon, and academic leader. He is the Carl and Elizabeth Naumann Dean of the Stanford University School of Medicine and Vice President for Medical Affairs at Stanford University. Dr. Minor is also a professor of Otolaryngology-Head and Neck Surgery and a professor of Bioengineering and of Neurobiology, by courtesy, at Stanford University.
As dean, Dr. Minor has had an integral role in setting strategy for the clinical enterprise of Stanford Medicine, an academic medical center that includes the Stanford School of Medicine, Stanford Health Care, and Stanford Medicine Children's Health. He oversees the quality of Stanford Medicine's physicians on the faculty and in the organization's growing clinical networks and physician practices. In August 2023, Dr. Minor was appointed as Vice President for Medical Affairs to lead all matters related to health and medicine at Stanford University.
Dr. Minor has demonstrated a steadfast commitment to diversity, equity, and inclusion. For example, between 2012 and 2022, the number of underrepresented students increased from 9.9 percent of incoming PhDs to 24.6 percent and from 14 percent of incoming MDs to 28.9 percent. Other key accomplishments include quadrupling the number of women department chairs and maintaining the highest NIH funding per faculty ratio in the country.
With Dr. Minor's leadership, Stanford Medicine is leading the biomedical revolution through Precision Health. Empowering people to lead healthy lives, Precision Health is a fundamental shift to more proactive and personalized health care that predicts and prevents disease before it strikes - and cures it decisively if it does. His book, "Discovering Precision Health: Predict, Prevent, and Cure to Advance Health and Well-Being," highlights how biomedical advances are dramatically improving our ability to treat and cure complex diseases.
Dr. Minor also spearheaded the creation of an Integrated Strategic Plan (ISP) that reaffirms Stanford Medicine's Precision Health vision. A groundbreaking roadmap launched in 2018, the ISP aligns Stanford Medicine's three entities, informs how each will develop strategies, and has activated dozens of high-impact initiatives across Stanford Medicine. In 2023, Dr. Minor and the CEOs of Stanford Health Care and Stanford Medicine Children's Health launched the ISP Refresh, an initiative focused on Stanford Medicine's evolution as it leads a biomedical landscape that has rapidly evolved due to COVID-19 and other developments.
At the beginning of the COVID-19 pandemic, Dr. Minor quickly implemented protocols to ensure the safety of patients and of the Stanford Medicine community. He emphasized open communication, transparency, and accountability as he and the leadership team responded to the unprecedented challenges that affected every facet of the enterprise's activities. Under his leadership, Stanford Medicine became one of the first academic medical centers to develop a COVID-19 test, launched hundreds of clinical research projects, and distributed 480,000 vaccine doses.
In 2021, Dr. Minor articulated and began realizing a bold vision for transforming the future of life sciences at Stanford University, in the Bay Area, and beyond. This multi-decade journey will leverage the region's unique strengths in information sciences, technology, and biology and biomedicine to establish a biomedical innovation hub that, through collaboration, enhances fundamental understanding of biology and translates promising discoveries into transformative leaps that promote human and planetary well-being.
Dr. Minor has long provided significant support for basic science research and for clinical and translational research at Stanford. Through bold initiatives in medical education and increased support for MD and PhD students, Dr. Minor is committed to inspiring and training future leaders. He also has increased student financial aid and expanded faculty leadership opportunities.
Among other accomplishments, Dr. Minor has led the development and implementation of an innovative model for cancer research and patient care delivery at Stanford Medicine and has launched an initiative in biomedical data science to harness the power of big data and create a learning health care system.
Before Stanford, Dr. Minor was provost and senior vice president for academic affairs of The Johns Hopkins University. As provost, Dr. Minor launched many university-wide initiatives such as the Gateway Sciences Initiative to support pedagogical innovation, and the Doctor of Philosophy Board to promote excellence in PhD education. He worked with others around the university and health system to coordinate the Individualized Health Initiative, which aimed to use genetic information to transform health care.
Prior to his appointment as provost in 2009, Dr. Minor was the Andelot Professor and director (chair) of the Department of Otolaryngology-Head and Neck Surgery in The Johns Hopkins University School of Medicine and otolaryngologist-in-chief of The Johns Hopkins Hospital. During his six-year tenure, he expanded annual research funding by more than half and increased clinical activity by more than 30 percent, while strengthening teaching efforts and student training.
With more than 160 published articles and chapters, Dr. Minor is an expert in balance and inner ear disorders. Through neurophysiological investigations of eye movements and neuronal pathways, his work has identified adaptive mechanisms responsible for compensation to vestibular injury in a model system for studies of motor learning (the vestibulo-ocular reflex). The synergies between this basic research and clinical studies have led to improved methods for the diagnosis and treatment of balance disorders. In recognition of his work in refining a treatment for Ménière's disease, Dr. Minor received the Prosper Ménière Society's gold medal in 2010.
In the medical community, Dr. Minor is perhaps best known for his discovery of superior canal dehiscence syndrome, a debilitating disorder characterized by sound- or pressure-induced dizziness. In 1998, Dr. Minor and colleagues published a description of the clinical manifestations of the syndrome and related its cause to an opening (dehiscence) in the bone covering the superior canal. He subsequently developed a surgical procedure that corrects the problem and alleviates symptoms.
Dr. Minor received his bachelor's and medical degrees from Brown University. He trained at Duke University Medical Center and the University of Chicago Medical Center and completed a research fellowship at the University of Chicago and a clinical fellowship at The Otology Group and The EAR Foundation in Nashville, Tennessee.
In 2012, Dr. Minor was elected to the National Academy of Medicine.
As part of the Stanford Executive Briefing series, Minor shares his thoughts on authentic leadership and offers five leadership principles.
Job Titles:
- Doctoral Dissertation Advisor ( AC )
Job Titles:
- Professor of Biochemistry, Emeritus
- Professor of Biochemistry, Emeritus / Research
Job Titles:
- Emeritus / Research Interests
Sleep researcher Emmanuel Mignot identifies the defective gene that causes narcolepsy, a disabling sleep disorder affecting humans and animals.
Pathologist Eugene Butcher discovers a receptor that guides white blood cells into the peripheral lymph nodes.
Pathologist Gerald Crabtree develops techniques that allow scientists to toggle genes on and off in animal models.
Job Titles:
- Professor of Medicine ( Oncology ) and of Biochemistry
- Professor of Medicine ( Oncology ) and of Biochemistry / Research
Job Titles:
- Professor of Developmental Biology, of Computer Science, of Pediatrics ( Genetics ) and of Biomedical Data Science
- Professor of Developmental Biology, of Computer Science, of Pediatrics ( Genetics ) and of Biomedical Data Science / Research
Gill Bejerano holds a B.Sc. In Mathematics, Physics and Computer Science, and a Ph.D in Computer Science (Machine Learning applications in Biology) from Hebrew University of Jerusalem. Gill got into genomics in 2003, started a wet lab in 2007, began analyzing patient genomes and medical records in 2014, got into cryptogenomics in 2017 and has become very interested in healthcare economics and patient risk management in 2021. He is recognized by multiple academic awards including two best paper and tomorrow's PI awards, Mallinckrodt, Sloan, Human Frontiers, Searle, Okawa, David and Lucile Packard, Microsoft and Sony Scholar awards. Gill has trained, collaborated and advised computational scientists, experimentalists, clinicians, and MBAs and has helped both start-ups and Fortune 500 companies.
Academic Appointments
Professor, Developmental Biology
Professor, Computer Science
Professor, Pediatrics - Medical Genetics
Professor, Department of Biomedical Data Science
Member, Bio-X
Member, Cardiovascular Institute
Faculty Affiliate, Institute for Human-Centered Artificial Intelligence (HAI)
Member, Maternal & Child Health Research Institute (MCHRI)
Member, Stanford Cancer Institute
Member, Wu Tsai Neurosciences Institute
Administrative Appointments
Member, Editorial Board, Gene (2007 - 2008)
Technical Advisory Board, Numenta (2008 - Present)
Job Titles:
- Master 's Program Advisor
Immunologist Hugh McDevitt discovers regulatory genes believed to control the body's reponses to foreign proteins, which suggests that people may have predictable susceptibility to certain diseases.
Job Titles:
- Professor of Biology / Research
Pathologist Irving Weissman isolates a rare mouse cell, known as the hematopoetic stem cell, which gives rise to all the cells of the blood and immune systems.
Pathologist Irving Weissman identifies the stem cell that gives rise to bladder cancer, and also shows how the cell uses the "don't-eat-me" signal, a molecule known as CD47, to evade the body's defenses.
Pathologist Irving Weissman shows that a single antibody, which counters the effect of the CD47 molecule, shrinks a variety of human tumors transplanted into mice.
Job Titles:
- Professor of Chemical and Systems Biology and of Biochemistry / Research
Job Titles:
- Professor of Medicine ( Oncology ) and of Genetics and, by Courtesy, of Pediatrics
Currently at Stanford Center for Professional Development, where she is working with Stanford faculty and industry experts to create online classes in the sciences.
Jan studied the breakdown (bleaching) of the cnidarian-dinoflagellate symbiosis under stress using the Aiptasia model system. By using different combinations of host animal and Symbiodinium strain type, she was able to distinguish the effects of the host genotype, the algal genotype, and the interactions between them on the stress resistance of the holobiont. The lab and its collaborators are still working to correlate these tightly controlled laboratory findings with the environmentally critical (but much less tractable experimentally) responses of coral/Symbiodinium holobionts to stress. Before joining the Pringle lab, Jan received her Ph.D. in Genetics from the University of North Carolina at Chapel Hill, where she studied the proteins involved in platelet activation.
Job Titles:
- Professor of Pathology / Research
Job Titles:
- Assistant Professor of Genetics / Research
Job Titles:
- Peter Wood Lead the First Large Clinical Investigation That Shows Lowering Cholesterol Levels Prevents Heart Disease
John Farquhar and Peter Wood lead the first large clinical investigation that shows lowering cholesterol levels prevents heart disease.
Job Titles:
- Director, CSIF, School of Medicine - CMGM
Job Titles:
- Summer Research Program for Teachers
Job Titles:
- Professor of Chemical and Systems Biology and, by Courtesy, of Biochemistry
Genomic instability contributes to many diseases, but it also underlies many natural processes. The Cimprich lab is focused on understanding how mammalian cells maintain genomic stability in the context of DNA replication stress and DNA damage. We are interested in the molecular mechanisms underlying the cellular response to replication stress and DNA damage as well as the links between DNA damage and replication stress to human disease.
Katherine Dexter McCormick and Stanley McCormick Memorial Professor, Stanford University School of Medicine (2022 - present)
Kenichi works on cell polarity and bud-site selection questions. He has left the Pringle Lab to work on a new project for the division of education at Obihiro University in Japan.
Job Titles:
- Lab Manager / Artist and Owner of Siamese Social Club
As a graduate student, I studied the phylogeny of nudibranchs at the California Academy of Sciences where I developed an interest in tropical marine invertebrates and aquarium husbandry. Now I am the lab manager in the Pringle Lab, where I get to work with literally thousands of marine invertebrates (i.e., anemones). Aside from keeping the lab's anemones happy, I take care of the lab's 50 gallon coral reef tank and have begun to test the usefulness of morpholinos as a method for gene knockdown in Aiptasia.
Job Titles:
- Professor in the School of Medicine, Professor of Genetics and of Medicine
Job Titles:
- Scientist at NASA Ames Research Center
Job Titles:
- Research Scientist at SyntheX Labs
Pathologist Marius Wernig turns mouse skin cells into cells that insulate neurons with the application of just three genes.
Immunologist Mark Davis characterizes the T-cell receptor, believed to regulate the body's response to infectious agents and cancerous diseases.
Job Titles:
- Professor of Radiation Oncology, Emeritus / Research
Mary Gohlke receives the world's first combined heart and lung transplant in a landmark operation led by surgeon Bruce Reitz.
Job Titles:
- Assistant Professor of Biology at Duke University
Job Titles:
- Executive Assistant to Dean Lloyd Minor, MD, Office of the Dean, Chief of Staff
Job Titles:
- Assistant Professor of Medicine ( Sean N Parker Center for Allergy and Asthma Research ) of Pathology and, by Courtesy, of Genetics
loves science and fast cars. For the science part, Meng was studying the molecular mechanisms of cytokinesis using the "Super" yeast Saccharomyces cerevisiae. The ongoing project focuses on the role of a protein complex in plasma membrane invagination and/or septum formation during cytokinesis. Meng was also interested in how protein modifications may regulate localization and interactions among the components of this complex during cytokinesis.
Job Titles:
- Professor of Genetics, Emerita / Research
Job Titles:
- Stanford Summer Research Program / Amgen Scholars
Job Titles:
- Principal Investigator and Director, PharmGKB, Biomedical Data Science
Job Titles:
- Professor ( Research ) of Genetics, Emeritus
- Professor ( Research ) of Genetics, Emeritus / Research
Job Titles:
- Clinical Associate Professor, Medicine - Oncology
Job Titles:
- Clinical Associate Professor, Medicine
Currently a graduate student in Biological Oceanography at the Scripps Institution of Oceanography.
I was a member of the Pringle lab during a much-too-brief 7-month period between finishing my undergraduate degree at UMD and before beginning my PhD. As a member of the lab, I worked on developing and testing candidate housekeeping genes for Aiptasia pallida for use in qPCR and on exploring dsRNA uptake for RNAi through agar bead mediated feeding. I was also very interested in and explored the role host cell apoptosis plays in the breakdown of the cnidarian-dinoflagellate symbiosis in response to thermal stress. Working in the Pringle lab also gave me the opportunity to try my hand at producing a lab video with my husband, which was a fun break from typical lab work.
Job Titles:
- Student in Genetics, Admitted Autumn 2018
Job Titles:
- Professor of Biochemistry, Emeritus / Research
Dr. Brown, currently an emeritus professor, is founder of Impossible Foods, a company dedicated to replacing the world's most destructive technology - the use of animals to transform plant biomass into meat, fish and dairy foods - by developing a new and better way to produce the world's most delicious, nutritious and affordable meats, fish and dairy foods directly from plants. Visit impossiblefoods.com for more information. He is also founder and president of the Impossible Foundation.
Job Titles:
- Associate Professor of Biochemistry
Job Titles:
- Professor of Microbiology and Immunology ( Baxter Labs ) and of Pathology / Research
Job Titles:
- Peter Wood Lead the First Large Clinical Investigation That Shows Lowering Cholesterol Levels Prevents Heart Disease
Job Titles:
- Adjunct Assistant Professor, Department of Biology, John Hopkins University
Job Titles:
- Lead Undergraduate Advising Director, Academic Advising Operations
Job Titles:
- Undergraduate Major Advisor
Surgeon Roy Cohn leads the first human kidney transplant operation on the West Coast.
I am fascinated by the dynamic nature of cytokinesis and the divergence of its mechanisms through evolution. Previously, I conducted plant cytokinesis research. Currently, I am working on the mechanisms of cleavage-furrow ingression and its coordination with actomyosin-ring contraction in the budding yeast Saccharomyces cerevisiae, which, unlike many other cell types, does not require the actomyosin ring for cytokinesis. Using genetic approaches that utilize this property as well as EM observations, interesting things are being revealed!
Radiologist Sanjiv Gambhir develops a new type of imaging system that can illuminate tumors in living subjects with a precision of nearly one-trillionth of a meter
Job Titles:
- Currently Lecturer at Portland Community College
I am interested in the molecular and cellular biology of cnidarian-dinoflagellate symbioses. Many ecologically important cnidarians, including sea anemones and tropical corals maintain an intracellular mutualism with unicellular dinoflagellate algae (Symbiodinium). Cnidarian-dinoflagellate symbioses provide a fascinating and grossly understudied set of problems in molecular, cell, and developmental biology. For example, we currently lack basic understanding of how host cells coordinate their cell cycles with those of their symbionts. My postdoctoral work focuses on this topic using the sea anemone Aiptasia pallida.
Job Titles:
- Professor of Applied Physics and of Physics, Emeritus
Job Titles:
- Assistant Professor of Medicine ( Cardiovascular Medicine ) and of Pediatrics
Job Titles:
- Postdoctoral Medical Fellow, Rheumatology Fellow in Pediatrics - Rheumatology / Clinical Focus / Rheumatology, Pediatrics, Fellow / 15 Total Publications
Job Titles:
- Res Scientist - Basic Ls, Neurosurgery
Job Titles:
- Professor of Developmental Biology, Emeritus / Research
Pediatrician Thomas Robinson finds that children who curtailed their television time gained significantly less body fat than those who didn't .
Job Titles:
- Professor of Genetics and of Pediatrics, Emerita
Job Titles:
- Professor of Genetics / Research
Researcher William Haskell shows that intensive lifestyle changes and prevention/treatment programs can reduce cardiac events and slow the progression of atherosclerosis in coronary arteries.
Researcher William S. Robinson isolates the genetic blueprint of a virus that causes hepatitis B and a common form of liver cancer.